ATE551065T1 - Zusammensetzungen mit igbpma und ihre verwendungen - Google Patents

Zusammensetzungen mit igbpma und ihre verwendungen

Info

Publication number
ATE551065T1
ATE551065T1 AT06808355T AT06808355T ATE551065T1 AT E551065 T1 ATE551065 T1 AT E551065T1 AT 06808355 T AT06808355 T AT 06808355T AT 06808355 T AT06808355 T AT 06808355T AT E551065 T1 ATE551065 T1 AT E551065T1
Authority
AT
Austria
Prior art keywords
igbpma
compositions containing
activation
agents
ticks
Prior art date
Application number
AT06808355T
Other languages
English (en)
Inventor
Hui Wang
Patricia Nuttall
Original Assignee
Natural Environment Res Council
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Natural Environment Res Council filed Critical Natural Environment Res Council
Application granted granted Critical
Publication of ATE551065T1 publication Critical patent/ATE551065T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43527—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from ticks
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AT06808355T 2005-11-01 2006-10-26 Zusammensetzungen mit igbpma und ihre verwendungen ATE551065T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0522298.9A GB0522298D0 (en) 2005-11-01 2005-11-01 Agents that bind IgE
PCT/GB2006/003986 WO2007051975A2 (en) 2005-11-01 2006-10-26 Compositions comprising igbpma and uses thereof

Publications (1)

Publication Number Publication Date
ATE551065T1 true ATE551065T1 (de) 2012-04-15

Family

ID=35516154

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06808355T ATE551065T1 (de) 2005-11-01 2006-10-26 Zusammensetzungen mit igbpma und ihre verwendungen

Country Status (7)

Country Link
US (1) US8343504B2 (de)
EP (1) EP1978990B1 (de)
JP (1) JP5123858B2 (de)
CN (1) CN101351216B (de)
AT (1) ATE551065T1 (de)
GB (1) GB0522298D0 (de)
WO (1) WO2007051975A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2394589T3 (es) 2007-12-14 2013-02-04 Aerodesigns, Inc Suministro de productos alimenticios transformables en aerosol
GB201203337D0 (en) 2012-02-24 2012-04-11 Natural Environment Res Council Method
CN110567787A (zh) * 2019-09-12 2019-12-13 浙江工商大学 一种快速纯化血清中IgG和IgE的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9406708D0 (en) 1994-04-05 1994-05-25 Mallinckrodt Veterinary Inc Vaccines
AU725630B2 (en) 1996-05-18 2000-10-19 Evolutec Limited Vasoactive amine binding molecules
AU2001232052A1 (en) * 2000-02-11 2001-08-20 Evolutec Limited Cytokine inhibitory molecules from tick salivary glands
WO2002094228A1 (en) 2001-05-23 2002-11-28 David Follansbee Prevention and treatment of allergies by helminthic regulation of ige
GB0307544D0 (en) 2003-04-01 2003-05-07 Evolutec Ltd Treatment method
DE602004022191D1 (de) * 2003-12-24 2009-09-03 Merck Serono Sa Coinsins Cc-chemokin-bindende zeckenproteine

Also Published As

Publication number Publication date
WO2007051975A3 (en) 2007-06-28
JP5123858B2 (ja) 2013-01-23
JP2009519213A (ja) 2009-05-14
US20080280828A1 (en) 2008-11-13
CN101351216B (zh) 2014-07-16
EP1978990B1 (de) 2012-03-28
CN101351216A (zh) 2009-01-21
US8343504B2 (en) 2013-01-01
GB0522298D0 (en) 2005-12-07
WO2007051975A2 (en) 2007-05-10
EP1978990A2 (de) 2008-10-15

Similar Documents

Publication Publication Date Title
ATE527365T1 (de) Il-15r alpha -sushi domäne als selektiver und effizienter verstärker der il-15-wirkung durch il-15rbeta/gamma , in hyperagonist il-15 ralpha sushi -il 15 fusionsproteine .
ATE481984T1 (de) Vakzine-peptid-kombinationen gegen katzenallergie
EA200802428A1 (ru) Комбинации агентов для биологической борьбы и нематоцидов, входящих в покрытие семян
ATE471334T1 (de) Phosphoramidatderivate von nukleosidverbindungen zur verwendung bei der behandlung von krebs
EA201000888A1 (ru) 4-фенилпиран-3,5-дионы, 4-фенилтиопиран-3,5-дионы и 2-фенилциклогексан-1,3,5-трионы в качестве гербицидов
WO2006133134A3 (en) Compositions comprising elemental metals and uses therefor
ATE460923T1 (de) Lyophilisierung von virosomen
MX2009000285A (es) Piperidinas sustituidas que incrementan la actividad de p53 y usos de las mismas.
NO20082240L (no) GLP-2 imitatorstoff, polypeptider, sammensetninger, fremgangsmater og anvendelser
UA101301C2 (ru) ВЫДЕЛЕННОЕ АНТИТЕЛО ПРОТИВ IL-23pl 9 И ЕГО ПРИМЕНЕНИЕ
CY1110981T1 (el) Πεπτιδια απευαισθητοποιησης εναντια στα αλλεργιογονα
ATE541928T1 (de) Inhibitoren der untereinheit 2 der ribonukleotidreduktase und ihre verwendungen
ATE546463T1 (de) Modifizierte humane wachstumshormon-polypeptide und ihre verwendungen
ATE554785T1 (de) Modifizierte fgf-21 polypeptide und ihre verwendung
ATE448206T1 (de) Benzochinazolinderivate und ihre verwendung bei der behandlung von knochenerkrankungen
EA200701396A1 (ru) Триазолофталазины в качестве ингибиторов pde-2
DK1877390T3 (da) Benzisoxazol-piperazin-forbindelser og fremgangsmåder til anvendelse deraf
ATE548035T1 (de) Formulierungen zur behandlung von lipoprotein- anormalitäten mit einem statin- und einem methylnicotinamid-derivat
PL1922128T3 (pl) Element do zmniejszania zawartości drobnego pyłu w powietrzu, za pomocą mchów i/lub porostów
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
DE602006003094D1 (de) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate zur behandlung von unfruchtbarkeit
ATE543833T1 (de) Bmp-7-varianten-zusammensetzungen, verfahren und verwendungen
TW200833248A (en) Bisoximes as fungicides
DE602006010737D1 (de) 3-(4-äÄ4-(4äÄ3-(3,3-DIMETHYL-1-PIPERIDINYL)PROPYLÄOXYÜPHINYLÜ-1-PIPERIDINYLCARBONYLü-1-NAPHTHALINYL)PROPAN- ODER PROPENSÄURE ALS H1- UND H3-REZEPTOR-ANTAGONISTEN ZUR BEHANDLUNG ENTZÜNDLICHER UND/ODER ALLERGISCHER ERKRANKUNGEN
EA200800389A1 (ru) Способ контроля сорняков